Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder-lack of effect of methylphenidate

Metabolic Brain Disease

Volumn 24, Issue 4, 2009, Pages 599-613

  Warton, Fleur L ^a   Howells, Fleur M ^a   Russell, Vivienne A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

ADHD; Behaviour; Dopamine; Glutamate; Locomotor activity; Methylphenidate; Open field; SHR

Indexed keywords

DOPAMINE; GLUTAMIC ACID; METHYLPHENIDATE; POTASSIUM ION; TRITIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG SELF ADMINISTRATION; HYPERACTIVITY; LOCOMOTION; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; WISTAR KYOTO RAT;

ACTION POTENTIALS; ANIMALS; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; EXPLORATORY BEHAVIOR; GLUTAMIC ACID; MALE; METHYLPHENIDATE; NEURONS; PRESYNAPTIC TERMINALS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SPECIES SPECIFICITY; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; UP-REGULATION; VENTRAL TEGMENTAL AREA;

ANIMALIA; RATTUS;

EID: 74449092826     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-009-9166-1     Document Type: Article

References (69)

1. CL Barr Y Feng K Wigg S Bloom W Roberts M Malone R Schachar R Tannock JL Kennedy 2000 Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder Mol Psychiatry 5 405 409 10.1038/sj.mp.4000733 1:CAS:528:DC%2BD3cXlslGjtLc%3D 10889551 (Pubitemid 30455954)
2. MA Bellgrove Z Hawi A Kirley M Gill IH Robertson 2005 Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype Neuropsychologia 43 1847 1857 10.1016/j. neuropsychologia.2005.03.011 16168728 (Pubitemid 41317401)
3. CW Berridge DM Devilbiss ME Andrzejewski AFT Arnsten AE Kelley B Schmeichel C Hamilton RC Spencer 2006 Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function Biol Psychiatry 60 1111 1120 10.1016/j.biopsych.2006. 04.022 1:CAS:528:DC%2BD28XhtFKmtLnO 16806100 (Pubitemid 44647216)
4. CL Brandon M Marinelli FJ White 2003 Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons Biol Psychiatry 54 1338 1344 10.1016/S0006-3223(03)00787-X 1:CAS:528: DC%2BD3sXpvVWqt74%3D 14675797 (Pubitemid 37522157)
5. E Carboni A Silvagni V Valentini G Di Chiara 2003 Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study Neurosci Biobehav Rev 27 653 659 10.1016/j.neubiorev.2003.08.008 1:CAS:528: DC%2BD3sXptVemu7Y%3D 14624809 (Pubitemid 37414913)
6. MP Carey LM Diewald FJ Esposito MP Pellicano UAG Carnevale JA Sergeant M Papa AG Sadile 1998 Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD Behav Brain Res 94 173 185 10.1016/S0166-4328(97)00178-2 1:CAS:528:DyaK1cXjs1arsLY%3D 9708848 (Pubitemid 28352473)
7. CJ Carter 1982 Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats Neuropharmacology 21 379 83 10.1016/0028-3908(82)90019-3 1:CAS:528: DyaL38Xks1Krtrw%3D 7110527
8. MA Cierpial DE Shasby CA Murphy AH Borom RE Stewart SE Swithers R McCarty 1989 Open field behaviour of spontaneously hypertensive and Wistar-Kyoto normotensive rats: effects of reciprocal cross-fostering Behav Neural Biol 51 203 210 10.1016/S0163-1047(89)90827-3 1:STN:280:DyaL1M7ptlalug%3D%3D 2930433 (Pubitemid 19068793)
9. KM Clements PE Wainwright 2007 Spontaneously hypertensive, Wistar Kyoto and Sprague-Dawley rats differ in performance on a win-stay task and a conditioned cue preference task in the water radial arm maze Behav Brain Res 183 169 177 10.1016/j.bbr.2007.06.008 1:STN:280:DC%2BD2sris1yjuw%3D%3D 17664015 (Pubitemid 47348129)
10. Coghill DR, Rhodes SM and Matthews K (2007). The neuropsychological effects of chronic methylphenidate on drug-naïve boys with attention-deficit/ hyperactivity disorder. Biol Psychiatry (Article in Press).
11. W Danysz A Plaznik O Pucilowski M Plewako M Obersztyn W Kostowski 1983 Behavioural studies in spontaneously hypertensive rats Behav Neural Biol 39 22 29 10.1016/S0163-1047(83)90569-1 1:STN:280:DyaL2c7gsVSgug%3D%3D 6686441
12. DD Dougherty AA Bonab TJ Spencer SL Rauch BK Madras AJ Fischman 1999 Dopamine transporter density in patients with attention deficit hyperactivity disorder Lancet 354 2132 2133 10.1016/S0140-6736(99)04030-1 1:CAS:528: DC%2BD3cXnt1Crug%3D%3D 10609822
13. S Durston NT Tottenham KM Thomas MC Davidson I-M Eigsti Y Yang AM Ulug BJ Casey 2003 Differential patterns of striatal activation in young children with and without ADHD Biol. Psychiatry 53 871 878 10.1016/S0006-3223(02)01904-2 12742674 (Pubitemid 36556172)
14. S Durston HE Hulshoff Pol HG Schnack JK Buitelaar MP Steenhuis RB Minderaa RS Kahn H van Engeland 2004 Magnetic resonance imaging of boys with attention deficit/ hyperactivity disorder and their unaffected siblings J. Am. Acad. Child Adolesc. Psychiatry 43 332 340 10.1097/00004583-200403000-00016 15076267 (Pubitemid 41615013)
15. M Ernst AJ Zametkin JA Matochik D Pascualvaca PH Jons RM Cohen 1999 High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder Am J Psychiatry 156 1209 1215 1:STN:280:DyaK1MznvVOmtA%3D%3D 10450262
16. M Federici R Geracitano G Bernardi NB Mercuri 2005 Actions of methylphenidate on dopaminergic neurons of the ventral midbrain Biol Psychiatry 57 361 365 10.1016/j.biopsych.2004.11.030 1:CAS:528:DC%2BD2MXhtlaisbY%3D 15705351 (Pubitemid 40215765)
17. Ferguson SA, Paule MG, Cada A, Fogle CM, Gray EP and Berry KJ (2007). Baseline behaviour, but not sensitivity to stimulant drugs, differs among Spontaneously Hypertensive, Wystar Kyoto and Sprague Dawley rat strains. Neurotoxicol Teratol (Article in Press).
18. MR Gerasimov M Franceschi ND Volkow A Gifford SJ Gatley D Marsteller PE Molina SL Dewey 2000 Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study In J Pharmacol Exp Ther 295 51 57 1:CAS:528:DC%2BD3cXnt1ygtLc%3D
19. T Hatzipetros BK Yamamoto 2006 Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra Brain Res. 1076 60 7 10.1016/j.brainres.2006.01.015 1:CAS:528: DC%2BD28XisF2msL4%3D 16680828 (Pubitemid 43376023)
20. CE Heise J Mitrofanis 2004 Evidence for a glutamatergic projection from the zona incerta to the basal ganglia of rats J Comp Neurol. 468 4 482 95 10.1002/cne.10971 1:CAS:528:DC%2BD2cXpvF2gug%3D%3D 14689481 (Pubitemid 38036690)
21. J Hood G Baird PM Rankin E Isaacs 2005 Immediate effects of methylphenidate on cognitive attention skills of children with attention deficit hyperactivity disorder Dev Med Child Neurol 47 408 414 10.1017/ S0012162205000794 15934489 (Pubitemid 40740500)
22. EB Johansen H Aase A Meyer T Sagvolden 2002 Attention-deficit/ hyperactivity disorder (ADHD) behaviour explained by dysfunctioning reinforcement and extinction processes Behav Brain Res 130 37 45 10.1016/S0166-4328(01)00434-X 11864716 (Pubitemid 34195319)
23. C Kieling T Roman AE Doyle MH Hutz LA Rohde 2006 Association between DRD4 gene and performance of children with ADHD in a test of sustained attention Biol Psychiatry 60 1163 1165 10.1016/j.biopsych.2006.04.027 1:CAS:528: DC%2BD28XhtFKmtLnJ 16781678 (Pubitemid 44647222)
24. S Knardahl T Sagvolden 1979 Open-field behaviour of spontaneously hypertensive rats Behav Neural Biol 27 187 200 10.1016/S0163-1047(79)91801-6 1:STN:280:DyaL3c%2FmsVKqtw%3D%3D 508216 (Pubitemid 10192099)
25. K-H Krause SH Dresel J Krause HF Kung K Tatsch 2000 Increased striatal dopamine transporter in adult patients with attention-deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography Neurosci Lett 285 107 110 10.1016/S0304-3940(00)01040-5 1:CAS:528:DC%2BD3cXivVGgurk%3D 10793238 (Pubitemid 30227631)
26. R Kuczenski DS Segal 2005 Stimulant actions in rodents: implications for attention deficit hyperactivity disorder treatment and potential substance abuse Biol Psychiatry 57 1391 1396 10.1016/j.biopsych.2004.12.036 1:CAS:528:DC%2BD2MXltFSrs7w%3D 15950013 (Pubitemid 40798560)
27. J Lasky-Su BM Neale B Franke RJ Anney K Zhou JB Maller, et al. 2008 Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations Am J Med Genet B Neuropsychiatr Genet 147B 1345 1354 10.1002/ajmg.b.30867 1:CAS:528:DC%2BD1cXhsFWktLrE 18821565
28. D Leo E Sorrentino F Volpicelli M Eyman D Greco D Viggiano U di Porzio C Perrone-Capano 2003 Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD Neurosci Biobehav Rev 27 661 669 10.1016/j.neubiorev.2003.08.009 1:CAS:528:DC%2BD3sXptVemu7c%3D 14624810 (Pubitemid 37414914)
29. Q Li G Lu GE Antonio YT Mak JA Rudd M Fan DT Yew 2007 The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain Neurochem Int 50 848 857 10.1016/j.neuint.2007.02.005 1:CAS:528:DC%2BD2sXltF2ls7w%3D 17395336 (Pubitemid 46722647)
30. M Lijffijt JL Kenemans A ter Wal EH Quik C Kemner H Westenberg MN Verbaten H van Engeland 2006 Dose-related effect of methylphenidate on stopping and changing in children with attention-deficit/ hyperactivity disorder Eur Psychiatry 21 544 547 10.1016/j.eurpsy.2005.04.003 15994064 (Pubitemid 44855524)
31. O Lindvall A Björklund 1978 Anatomy of the dopaminergic neuron systems in the rat brain Adv Biochem Psychopharmacol. 19 1 23 1:CAS:528:DyaE1cXmtFantLk%3D 358775
32. MS Mazei-Robison RS Couch RC Shelton MA Stein RD Blakely 2005 Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder Neuropharmacology 49 724 736 10.1016/j. neuropharm.2005.08.003 1:CAS:528:DC%2BD2MXhtFehs7fO 16171832 (Pubitemid 41483879)
33. M Ohadi E Shirazi M Tehranodoosti N Moghimi MR Keikhaee S Ehssani A Aghajani H Najmabadi 2006 Attention-deficit/ hyperactivity disorder (ADHD) association with the DAT1 core promoter -67 T allele Brain Res 1101 1 4 10.1016/j.brainres.2006.05.024 1:CAS:528:DC%2BD28XntVWjtrY%3D 16782077 (Pubitemid 44055926)
34. K Okamoto K Aoki 1963 Development of a strain of spontaneously hypertensive rats Jpn Circ J 27 282 293 1:STN:280:DyaF387jtFCmsw%3D%3D 13939773
35. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, San Diego
36. G Polanczyk MS de Lima BL Horta J Biederman LA Rohde 2007 The worldwide prevalence of ADHD: a systematic review and metaregression analysis Am J Psychiatry 164 942 948 10.1176/appi.ajp.164.6.942 17541055 (Pubitemid 46972911)
37. A Ramos P Morméde 1998 Stress and emotionality: a multidimensional and genetic approach Neurosci Biobehav Rev 22 33 57 10.1016/S0149-7634(97) 00001-8 1:STN:280:DyaK1c7ltV2jsQ%3D%3D 9491939 (Pubitemid 28082283)
38. A Ramos O Berton P Mormede F Chaouloff 1997 A multiple-test study of anxiety-related behaviours in six inbred rat strains Behav Brain Res 85 57 69 10.1016/S0166-4328(96)00164-7 1:STN:280:DyaK2s3kvFCmtA%3D%3D 9095342 (Pubitemid 27116150)
39. P Rosa-Neto HC Lou P Cumming O Pryds H Karrebaek J Lunding A Gjedde 2005 Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention-deficit hyperactivity disorder Neuroimage 25 868 876 10.1016/j.neuroimage.2004.11.031 15808987 (Pubitemid 40461725)
40. DN Ruskin DA Bergstrom A Shenker LE Freeman D Baek JR Walters 2001 Drugs used in the treatment of attention-deficit/ hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action Biol Psychiatry 49 340 350 10.1016/S0006-3223(00)00987-2 1:CAS:528:DC%2BD3MXhs1Cjt70%3D 11239905 (Pubitemid 32182364)
41. VA Russell 2000 The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat as studied in vitro by the superfusion slice technique Neurosci Biobehav Rev 24 133 136 10.1016/S0149-7634(99)00056-1 1:CAS:528:DC%2BD3cXjtVyluw%3D%3D 10654669 (Pubitemid 30026155)
42. VA Russell 2003 In vitro glutamate-stimulated release of dopamine from nucleus accumbens core and shell of spontaneously hypertensive rats Metab Brain Dis. 18 161 168 10.1023/A:1023819220840 1:CAS:528:DC%2BD3sXjvVagsbY%3D 12822835 (Pubitemid 36718129)
43. VA Russell 2007 Neurobiology of animal models of attention-deficit hyperactivity disorder J Neurosci Methods 161 185 198 10.1016/j.jneumeth.2006. 12.005 17275916 (Pubitemid 46466956)
44. V Russell A de Villiers T Sagvolden M Lamm J Taljaard 1995 Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder-the spontaneously hypertensive rat Brain Res 676 343 451 10.1016/0006-8993(95)00135-D 1:CAS:528:DyaK2MXkvFGmsbk%3D 7614004
45. V Russell A de Villiers T Sagvolden M Lamm J Taljaard 1998 Differences between electrically-, Ritalin- and D-amphetamine-stimulated release of [3H]-dopamine from brain slices suggests impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder Behav Brain Res 94 163 171 10.1016/S0166-4328(97)00177-0 1:CAS:528:DyaK1cXjs1arsLg%3D 9708847 (Pubitemid 28352472)
46. VA Russell AS de Villiers T Sagvolden MCL Lamm JJF Taljaard 2000 Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/ hyperactivity disorder-the spontaneously hypertensive rat Brain Res Bull 53 187 192 10.1016/S0361-9230(00)00324-5 1:CAS:528: DC%2BD3cXotVWls70%3D 11044595 (Pubitemid 30759063)
47. Russell VA, Sagvolden T, Johansen EB (2005) Animal models of attention-deficit hyperactivity disorder. Behav Brain Function 1:9
48. T Sagvolden 2000 Behavioural validation of the spontaneously hypertensive rat (SHR) as an animal model of attention deficit/ hyperactivity disorder (AD/HD) Neurosci Biobehav Rev 24 31 39 10.1016/S0149-7634(99)00058-5 1:STN:280:DC%2BD3c7hvVyiuw%3D%3D 10654658 (Pubitemid 30026144)
49. T Sagvolden JA Sergeant 1998 Attention deficit hyperactivity disorder-from brain dysfunction to behaviour Behav Brain Res 94 1 10 10.1016/S0166-4328(97)00170-8 1:STN:280:DyaK1cznt1Gltw%3D%3D 9708834 (Pubitemid 28352465)
50. T Sagvolden EB Johansen H Aase VA Russell 2005 A dynamic developmental theory of Attention-Deficit/Hyperactivity Disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes Behav. Brain Sci. 28 397 419 10.1017/S0140525X05000075 16209748 (Pubitemid 41440193)
51. T Sagvolden VA Russell A Aase EB Johansen M Farshbaf 2005 Rodent models of attention-deficit/hyperactivity disorder Biol. Psychiatry 57 1239 1247 10.1016/j.biopsych.2005.02.002 15949994 (Pubitemid 40798541)
52. E Scarnati A Proia E Campana C Pacitti 1986 A microiontophoretic study on the nature of the putative synaptic neurotransmitter involved in the pedunculopontine-substantia nigra pars compacta excitatory pathway of the rat Exp. Brain Res. 62 470 8 10.1007/BF00236025 1:CAS:528:DyaL28XltV2iu74%3D 2873047
53. R-Y Shen K-C Choong 2006 Different adaptations in ventral tegmental area dopamine neurons in control and ethanol exposed rats after methylphenidate treatment Biol Psychiatry 59 635 642 10.1016/j.biopsych.2005.08.021 1:CAS:528:DC%2BD28Xit1Ojurw%3D 16199009 (Pubitemid 43357958)
54. MV Solanto 1998 Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration Behav Brain Res 94 127 152 10.1016/S0166-4328(97)00175-7 1:CAS:528: DyaK1cXjs1arsL8%3D 9708845 (Pubitemid 28352470)
55. TJ Spencer J Biederman BK Madras DD Dougherty AA Bonab E Livni PC Meltzer J Martin S Rauch AJ Fischman 2007 Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane Biol. Psychiatry 62 1059 1061 10.1016/j.biopsych.2006.12.008 1:CAS:528: DC%2BD2sXhtF2htbfP 17511972 (Pubitemid 47562362)
56. GA Sunohara MA Malone J Rover T Humphries W Roberts MJ Taylor 1999 Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evidence Neuropsychopharmacology 21 218 228 10.1016/S0893-133X(99)00023-8 1:CAS:528:DyaK1MXltVOntrY%3D 10432470 (Pubitemid 29304583)
57. J Swanson FX Castellanos M Murias G LaHoste J Kennedy 1998 Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder Curr Opin Neurobiol 8 263 271 10.1016/S0959-4388(98)80150-5 1:CAS:528:DyaK1cXjvFeisLc%3D 9635212 (Pubitemid 28247810)
58. JM Swanson M Kinsbourne J Nigg B Lanphear GA Stefanatos N Volkow E Taylor BJ Casey FX Castellanos PD Wadhwa 2007 Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis Neuropsychol Rev 17 39 59 10.1007/s11065-007-9019-9 17318414 (Pubitemid 46355008)
59. A Thapar M O'Donovan MJ Owen 2005 The genetics of attention deficit hyperactivity disorder Hum Mol Genet 14 2 275 282 10.1093/hmg/ddi263 (Pubitemid 41631896)
60. S-J Tsai 2006 Signal transducer and activator of transcription 6 (STAT6) and attention-deficit hyperactivity disorder: a speculative hypothesis Med Hypotheses 67 1341 1343
61. MA Van der Kooij JC Glennon 2007 Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder Neurosci Biobehav Rev 31 597 618 10.1016/j.neubiorev.2006.12.002 17316796 (Pubitemid 46527883)
62. D Van't Ent H Lehn EM Derks JJ Hudziak NM van Strien DJ Veltman EJC De Geus RD Todd DI Boomsma 2007 A structural MRI study in monozygotic twins concordant or discordant for attention/ hyperactivity problems: evidence for genetic and environmental heterogeneity in the developing brain Neuroimage 35 1004 1020 10.1016/j.neuroimage.2007.01.037 (Pubitemid 46507840)
63. ND Volkow G-J Wang J Newcorn JS Fowler F Telang MV Solanto J Logan C Wong Y Ma JM Swanson K Schultz K Pradhan 2007 Brain dopamine transporter levels in treatment and drug naïve adults with ADHD Neuroimage 34 1182 1190 10.1016/j.neuroimage.2006.10.014 17126039
64. Y Watanabe M Fujita Y Ito T Okada H Kusuoka T Nishimura 1997 Brain dopamine transporter in spontaneously hypertensive rats J Nucl Med 38 470 474 1:CAS:528:DyaK2sXitleit7k%3D 9074541
65. TE Wilens J Biederman TJ Spencer 2002 Attention deficit/ hyperactivity disorder across the lifespan Annu Rev Med 53 113 131 10.1146/annurev.med.53. 082901.103945 1:CAS:528:DC%2BD38Xitl2msbY%3D 11818466 (Pubitemid 34177874)
66. R Wise 2008 Dopamine and reward: the anhedonia hypothesis 30 years on Neurotox. Res. 14 169 83 10.1007/BF03033808 19073424
67. B Wultz T Sagvolden E Moser M-B Moser 1990 The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behaviour Behav Neural Biol 53 88 102 10.1016/0163-1047(90)90848-Z 1:CAS:528:DyaK3cXhtFWqtrc%3D 2302145
68. PB Yang B Amini AC Swann N Dafny 2003 Strain differences in the behavioural responses of male rats to chronically administered methylphenidate Brain Res 971 139 152 10.1016/S0006-8993(02)04240-3 1:CAS:528: DC%2BD3sXivFequ78%3D 12706230 (Pubitemid 36423316)
69. J-W Yang W-S Jang SD Hong YI Ji DH Kim J Park SW Kim YS Joung 2008 A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit hyperactivity disorder: evidence of association with the -521 C/T SNP Prog Neuropsychopharmacol Biol Psychiatry 32 243 248 10.1016/j.pnpbp.2007.08.016 1:CAS:528: DC%2BD1cXptlajtg%3D%3D 17850946